NBY NovaBay(R) Pharmaceuticals to Present at Rodman & Renshaw 11th Annual Healthcare Conference
NovaBay(R) Pharmaceuticals
NovaBay(R) Pharmaceuticals, a clinical stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a wide range of bacterial, viral and fungal infections, announced today that Ron Najafi, Ph.D., Chairman and Chief Executive Officer, will present at the Rodman & Renshaw 11th Annual Healthcare Conference at 10 a.m., Thursday, Sept. 10, 2009 at the New York Palace Hotel in New York City.
StockEinstein.com offers free trading alerts on stocks about to run. To sign up for our free alert service please click here www.stockeinstein.com or scroll to bottom of this page to sign up.
NovaBay Pharmaceuticals, Inc. (NovaBay) is a clinical-stage biopharmaceutical company developing synthetic anti-infective product candidates to treat and prevent a range of infections, without developing resistance, in hospital and non-hospital environments. The Company’s Aganocide compounds are synthetic forms of N-chlorinated antimicrobial molecules, which are effective and acting anti-infective molecules produced by white blood cells when defending the body against invading pathogens. In preclinical testing, its Aganocide compounds have demonstrated the ability to destroy bacteria, against which they have been tested. On March 25, 2009, the Company announced that it had entered into an agreement with Galderma S.A. to develop and commercialize its Aganocide compounds.
About StockEinstein
StockEinstein.com uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
Thank you for your interest in Findit News. A member of the Findit News team will contact you soon to show you how you can take your marketing to the next level with press releases on Findit.
